Overall Fundamental outlook

Business Operations:

Sector: Consumer Defensive
Industry: Household & Personal Products

Emami Limited manufactures and markets personal and healthcare products in India and internationally. It provides ayurvedic antiseptic cream, prickly heat powder, doodh kesar body lotion, aloe neem lotion, vasocare herbal petroleum jelly, coconut oil, aloe vera gel, and hygiene products under the Boroplus brand; cool oil, extra thanda, gold ayurvedic oil, therapy ayurvedic body massage and stress relief oil, maxx cool talc, and cool talc under the Navratna brand; and balm, balm ultra-power, quick relief roll-on, ortho vedic oil, ointment, relief gel and spray, healthcare products, pancharishta, nityam, and kesari jivan under the Zandu brand. The company also offers radiance cream and instant radiance face wash for men under the Fair and Handsome brand; haircare products and shampoo under the Kesh King brand; balm under the Mentho Plus brand; prickly heat powder under the Dermicool brand; hair oil, shampoos, and conditioners under the Emami 7 Oils in One brand; deodorants under the HE brand; hair colors under the Emami Diamond Shine brand; talc under the Emami Golden Beauty brand; herbal fairness cream under the Emami Naturally Fair brand; toothpaste under the Ayucare brand; hair colors and oils under the Emami Gold brand; and moisturisers, lotion, soft creams, glycerine creams and oils, petroleum jelly, baby shampoos, and other skin products under the Cream21 brand. Emami Limited was founded in 1974 and is headquartered in Kolkata, India.

Revenue projections:

Revenue projections for EMAMILTD
Revenue projections for EMAMILTD

With EMAMILTD's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.

Financial Ratios:

currentRatio 2.224000
forwardPE 23.962732
debtToEquity 3.333000
earningsGrowth 0.091000
revenueGrowth 0.081000
grossMargins 0.686490
operatingMargins 0.182660
trailingEps 18.490000
forwardEps 0.000000

EMAMILTD's current ratio is 2.224, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as EMAMILTD should not face any issues meeting its short-term liabilities with available resources.
EMAMILTD's Forward PE being in a good range indicates that the stock is valued appropriately based on its earnings. This suggests the stock is not overpriced and leaves room for growth, providing investors with an opportunity for potential appreciation in value.

Price projections:

Price projections for EMAMILTD
Price projections for EMAMILTD

EMAMILTD's price projections have steadily declined, indicating that analysts are revising their outlook on the company. This downward trend reflects a more cautious perspective on EMAMILTD's future growth prospects.

Recommendation changes over time:

Recommendations trend for EMAMILTD
Recommendations trend for EMAMILTD


The recent buy bias for EMAMILTD from analysts signals strong confidence in the stock's potential. This positive sentiment could encourage investors to see EMAMILTD as a smart place to invest their money, especially those looking for stable, long-term returns in a well-established company.